Key result
In-hospital glucose therapy intensification was not associated with 30-day readmission overall (OR 0.94; 95% CI 0.64-1.37), but reduced risk in patients with HbA1c ≥8% (OR 0.33; 95% CI 0.12-0.88).
Why the study?
Does glucose therapy intensification during hospitalization reduce 30-day unplanned readmission or emergency department admission in adults with Type 2 diabetes?
Population
1,949 adults with Type 2 diabetes receiving primary care within an academic health network admitted to the…
Comparison
Glucose therapy intensification during… vs No glucose therapy intensification during…
Design
Cohort
Follow-up
30 days
Authors
Loading...
Glucose intensification may warrant consideration only in HbA1c ≥8%; leaves open whether randomized trials should test targeted use.
Cohort (n=1,949)
Does glucose therapy intensification during hospitalization reduce 30-day unplanned readmission or emergency department admission in adults with Type 2 diabetes?
Odds Ratio: 0.94 (95% CI 0.64–1.37)
p-value: p=0.74
In-hospital diabetes regimen intensification is safe and associated with reduced 30-day readmission and improved outpatient glycemic control in patients with poorly controlled baseline HbA1c.
Wei et al. (2012) conducted a cohort in Type 2 diabetes (n=1,949). Glucose therapy intensification vs. No glucose therapy intensification was evaluated on 30-day risk for unplanned readmission/emergency department admission (OR 0.94, 95% CI 0.64-1.37, p=0.74). In-hospital glucose therapy intensification was not associated with 30-day readmission overall (OR 0.94; 95% CI 0.64-1.37), but reduced risk in patients with HbA1c ≥8% (OR 0.33; 95% CI 0.12-0.88).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: